What is Immix Biopharma, Inc. Common Stock's Market Cap?

Immix Biopharma, Inc. Common Stock's Market Cap is $995.1M, based on as-reported figures from SEC (XBRL) filings.

What is Immix Biopharma, Inc. Common Stock's Enterprise Value?

Immix Biopharma, Inc. Common Stock's Enterprise Value is $763.0M, based on as-reported figures from SEC (XBRL) filings.

What is Immix Biopharma, Inc. Common Stock's EV / EBITDA?

Immix Biopharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Immix Biopharma, Inc. Common Stock's Net Income (TTM)?

Immix Biopharma, Inc. Common Stock's Net Income (TTM) is -$39.9M, based on as-reported figures from SEC (XBRL) filings.

What is Immix Biopharma, Inc. Common Stock's EBITDA?

Immix Biopharma, Inc. Common Stock's EBITDA is -$41.5M, based on as-reported figures from SEC (XBRL) filings.

What is Immix Biopharma, Inc. Common Stock's Diluted EPS (TTM)?

Immix Biopharma, Inc. Common Stock's Diluted EPS (TTM) is -0.56, based on as-reported figures from SEC (XBRL) filings.

What is Immix Biopharma, Inc. Common Stock's Net Debt?

Immix Biopharma, Inc. Common Stock's Net Debt is -$232.1M, based on as-reported figures from SEC (XBRL) filings.

Immix Biopharma, Inc. Common Stock (IMMX) Financial Statements

Immix Biopharma, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00HLCWH18

XNAS · usd

13.91▲ 0.00 (0.00%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close13.91

Day's Range13.60 – 14.09

52-Week Range1.94 – 15.10

Volume1.0M

Avg Volume1.5M

Share Statistics

Shares Outstanding

Employees21

ExchangeXNAS

Listed2021-12-16

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Immix Biopharma, Inc. Common Stock (IMMX)

What is Immix Biopharma, Inc. Common Stock's Market Cap?: Immix Biopharma, Inc. Common Stock's Market Cap is $995.1M, based on as-reported figures from SEC (XBRL) filings.
What is Immix Biopharma, Inc. Common Stock's Enterprise Value?: Immix Biopharma, Inc. Common Stock's Enterprise Value is $763.0M, based on as-reported figures from SEC (XBRL) filings.
What is Immix Biopharma, Inc. Common Stock's EV / EBITDA?: Immix Biopharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Immix Biopharma, Inc. Common Stock's Net Income (TTM)?: Immix Biopharma, Inc. Common Stock's Net Income (TTM) is -$39.9M, based on as-reported figures from SEC (XBRL) filings.
What is Immix Biopharma, Inc. Common Stock's EBITDA?: Immix Biopharma, Inc. Common Stock's EBITDA is -$41.5M, based on as-reported figures from SEC (XBRL) filings.
What is Immix Biopharma, Inc. Common Stock's Diluted EPS (TTM)?: Immix Biopharma, Inc. Common Stock's Diluted EPS (TTM) is -0.56, based on as-reported figures from SEC (XBRL) filings.
What is Immix Biopharma, Inc. Common Stock's Net Debt?: Immix Biopharma, Inc. Common Stock's Net Debt is -$232.1M, based on as-reported figures from SEC (XBRL) filings.